Monitoring both PSA and testosterone levels in advanced prostate cancer

Monitoring both PSA and testosterone levels in advanced prostate cancer

Hear from international speaker, Prof Axel Merseburger, as he reviews the importance of monitoring PSA and testosterone levels in advanced prostate cancer and how they correlate with prognosis.

Language Icon English
duration 02:43
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300106
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

Wieder On-Demand

Webinar Recording: LHRH Suppression and its role as foundational care in the treatment of prostate cancer

Dr Jeff Wieder presents an insightful webinar on luteinising hormone-releasing hormone (LHRH) suppression and its role in the treatment of patients with prostate cancer.

Language Icon English
duration 51:30
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Webinar

Job Code : 

AU-ELI-2300075
Prostate Cancer

Dr jeff

Dr Jeff Wieder

Clinical Urologist and author of "The Pocket Guide to Urology"

Wieder Q&A

Webinar Q&A: LHRH Suppression and its role as foundational care in the treatment of prostate cancer

Dr Jeff Wieder presents the Q&A section from his webinar on luteinising hormone-releasing hormone (LHRH) suppression and its role in the treatment of patients with prostate cancer.

Language Icon English
duration 19:00
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Webinar

Job Code : 

AU-ELI-2300076
Prostate Cancer

Dr jeff

Dr Jeff Wieder

Clinical Urologist and author of "The Pocket Guide to Urology"

Advanced delivery of leuprorelin acetate for the treatment of prostate cancer

International expert and author summary

Watch Professor Axel Merseburger's summary of his expert review publication "Advanced delivery of leuprorelin acetate for the treatment of prostate cancer".

Language Icon English
duration 3:18
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300065
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

patient receptivity to 6-monthly luteinizing hormone releasing hormone (LHRH) agonist therapy

International expert opinion: luteinizing hormone gonadotropin-releasing hormone

Watch Professor Axel Merseburger's expert summary on patient receptivity to 6-monthly luteinizing hormone releasing hormone (LHRH) agonist therapy.

Language Icon English
duration 2:36
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300070
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

testosterone suppression and testing during androgen deprivation therapy

International expert opinion: androgen deprivation therapy

Watch Professor Axel Merseburger's expert summary on the importance of testosterone suppression and testing during treatment on androgen deprivation therapy.

Language Icon English
duration 3:09
Event topic Icon

Eligard® - Prostate Cancer

Event Icon Video

Job Code : 

AU-ELI-2300069
Prostate Cancer

Dr Axel Merseburger

Dr Axel Merseburger

Chairman of the Department of Urology at the University Hospital Schleswig-Holstein in Lübeck, Germany

Anatomy model

Anatomy Resource for Healthcare Professionals

Prostate Anatomy Model

Urology App

Educational Resource for Healthcare Professionals

Urology Fellowship Handbook App

A complimentary token to access and download the Urology Fellowship Handbook on your smart device

eligard injection playbook

Instructional Resource for Healthcare Professionals

ELIGARD® Mixing and Administration Guide

A comprehensive and easy to follow guide on preparing, mixing and administering ELIGARD®

Eligard demo kit

ELIGARD® - Prostate Cancer

ELIGARD® Demonstration Kits for Healthcare Professionals

Subscribe to Prostate Cancer